Knee Replacements are on the Up

In the US, spending to treat all orthopaedic problems including pain in the muscles, bones and joints represents about 15 percent of overall healthcare outlay for those with medical insurance.

The Blue Cross Blue Shield Association is a US federation of health insurers with more than 106 million people on their books. In a recent report they note that spending on planned knee and hip replacements is increasing, driven mainly by an increase in the number of procedures among people under 65. The number of knee replacements increased by 17% between 2010 and 2017, and hip replacements rose by 33%.



Vestact portfolio holders are invested in leading knee joint manufacturers, Stryker and Johnson & Johnson's Synthes division.

You can read the longer Blue Cross Blue Shield Association Report if you have the time.